Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles

Showing results (71-80 of 668) with videos related to

Pageof 67
Sort By:
Leukemia & Lymphoma|January 21, 2012
Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trialsH Miles Prince
Journal of the American Geriatrics Society|September 1, 1990
Resuscitating the nursing home resident. Futility and pseudofutilityS H Miles
Blood|November 8, 2014
Identifying mutant pathways in the histiocytosesH Miles Prince
British Journal of Haematology|August 10, 2021
A cautionary tale of the use of lenalidomide and dexamethasone for relapsed/refractory immunoglobulin light chain (AL) amyloidosisH Miles Prince
Annals of Internal Medicine|January 22, 2000
The health effects of economic sanctions and embargoes: the role of health professionals. Ethics and Human Rights CommitteeK Morin, S H Miles
Annals of Internal Medicine|February 15, 2003
Hospice benefits and phase I cancer trialsIra Byock, Steven H Miles
Leukemia & Lymphoma|November 17, 2006
Myeloma, thalidomide and thrombosisDirk Hönemann, H Miles Prince
BMJ (Clinical Research Ed.)|March 24, 2016
Should doctors boycott working in Australia's immigration detention centres?David Berger, Steven H Miles
Leukemia & Lymphoma|November 17, 2006
The troublesome toxicity of peripheral neuropathy with thalidomideLinda Mileshkin, H Miles Prince
Expert Review of Hematology|May 4, 2021
An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myelomaAnna Piggin, H Miles Prince
Pageof 67

Showing results (71-80 of 668) with videos related to

Sort By:
Pageof 67
Leukemia & Lymphoma|January 21, 2012
Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trialsH Miles Prince
Journal of the American Geriatrics Society|September 1, 1990
Resuscitating the nursing home resident. Futility and pseudofutilityS H Miles
Blood|November 8, 2014
Identifying mutant pathways in the histiocytosesH Miles Prince
British Journal of Haematology|August 10, 2021
A cautionary tale of the use of lenalidomide and dexamethasone for relapsed/refractory immunoglobulin light chain (AL) amyloidosisH Miles Prince
Annals of Internal Medicine|January 22, 2000
The health effects of economic sanctions and embargoes: the role of health professionals. Ethics and Human Rights CommitteeK Morin, S H Miles
Annals of Internal Medicine|February 15, 2003
Hospice benefits and phase I cancer trialsIra Byock, Steven H Miles
Leukemia & Lymphoma|November 17, 2006
Myeloma, thalidomide and thrombosisDirk Hönemann, H Miles Prince
BMJ (Clinical Research Ed.)|March 24, 2016
Should doctors boycott working in Australia's immigration detention centres?David Berger, Steven H Miles
Leukemia & Lymphoma|November 17, 2006
The troublesome toxicity of peripheral neuropathy with thalidomideLinda Mileshkin, H Miles Prince
Expert Review of Hematology|May 4, 2021
An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myelomaAnna Piggin, H Miles Prince
Pageof 67